Empresa TriSalus Life Sciences, Inc.
Acciones
TLSI
US89680M1018
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
5,76 USD | +1,95 % |
|
+1,23 % | -31,83 % |
03/06 | TriSalus Life Sciences, Inc. destaca los datos clínicos del ensayo de fase 1b Perio-02 | CI |
30/05 | TRISALUS LIFE SCIENCES, INC. : Obtiene una recomendación de compra de Canaccord Genuity | ZM |
Resumen de negocios
Número de empleados: 101
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Innovative Drug Delivery Technology and Immune-oncology Therapeutics
100,0
%
| - | - | 19 | 100,0 % | - |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 19 | 100,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Mary Szela
CEO | Chief Executive Officer | 60 | 01/01/18 |
Sean Murphy
DFI | Director of Finance/CFO | 71 | 10/08/23 |
Steven Katz
CTO | Chief Tech/Sci/R&D Officer | 49 | 10/08/23 |
Bryan Cox
CTO | Chief Tech/Sci/R&D Officer | 62 | 10/08/23 |
Jennifer Stevens
LAW | General Counsel | 63 | 10/08/23 |
Richard Marshak
PRN | Corporate Officer/Principal | 65 | 10/08/23 |
Jodi Devlin
PRN | Corporate Officer/Principal | - | 05/09/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Kerry Hicks
BRD | Director/Board Member | 64 | 10/08/23 |
Mats Wahlström
CHM | Chairman | 70 | 10/08/23 |
George Martin
BRD | Director/Board Member | 65 | 10/08/23 |
David Matlin
BRD | Director/Board Member | 62 | 10/08/23 |
Sean Murphy
DFI | Director of Finance/CFO | 71 | 10/08/23 |
Mary Szela
CEO | Chief Executive Officer | 60 | 01/01/18 |
Director/Board Member | 82 | 10/08/23 | |
Arjun Desai
BRD | Director/Board Member | 42 | 10/08/23 |
Anil Singhal
BRD | Director/Board Member | 72 | 10/08/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 27 159 327 | 12 627 881 ( 46,50 %) | 0 | 46,50 % |
Información de la empresa
![Dirección TriSalus Life Sciences, Inc.(TLSI)](https://cdn.zonebourse.com/static/address/158015062.png)
Sector
![Consenso](/images/consensus_flch.gif)
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-31,83 % | 150 M | |
+15,20 % | 121 mil M | |
+19,67 % | 113 mil M | |
+18,95 % | 26,02 mil M | |
-23,86 % | 19,39 mil M | |
-19,03 % | 15,91 mil M | |
-20,90 % | 15,09 mil M | |
-46,14 % | 15,06 mil M | |
+63,85 % | 14,93 mil M | |
+4,49 % | 13,85 mil M |
- Bolsa de valores
- Acciones
- Acción TLSI
- Empresa TriSalus Life Sciences, Inc.